Efficacy of the MAGE-A3 cancer immunotherapeutic as adjuvant therapy in patients with resected MAGE-A3-positive non-small-cell lung cancer (MAGRIT): a randomised, double-blind, placebo-controlled, phase 3 trial (Q40692551)
Jump to navigation
Jump to search
scientific article published on 27 April 2016
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Efficacy of the MAGE-A3 cancer immunotherapeutic as adjuvant therapy in patients with resected MAGE-A3-positive non-small-cell lung cancer (MAGRIT): a randomised, double-blind, placebo-controlled, phase 3 trial |
scientific article published on 27 April 2016 |
Statements
1 reference
Efficacy of the MAGE-A3 cancer immunotherapeutic as adjuvant therapy in patients with resected MAGE-A3-positive non-small-cell lung cancer (MAGRIT): a randomised, double-blind, placebo-controlled, phase 3 trial (English)
1 reference
1 reference
Jacek Jassem
1 reference
Jubrail Dahabreh
1 reference
Johan F Vansteenkiste
1 reference
Tonu Vanakesa
1 reference
Tommaso De Pas
1 reference
Marcin Zielinski
1 reference
Moon Soo Kim
1 reference
Masahiro Yoshimura
1 reference
Haruhiku Nakayama
1 reference
Libor Havel
1 reference
Haruhiko Kondo
1 reference
Konstantinos Zarogoulidis
1 reference
Oleg A Gladkov
1 reference
Katalin Udud
1 reference
Hirohito Tada
1 reference
Hans Hoffman
1 reference
Anders Bugge
1 reference
Paul Taylor
1 reference
Emilio Esteban Gonzalez
1 reference
Mei Lin Liao
1 reference
Jianxing He
1 reference
Jean-Louis Pujol
1 reference
Jamila Louahed
1 reference
Muriel Debois
1 reference
Vincent Brichard
1 reference
Channa Debruyne
1 reference
Patrick Therasse
1 reference
Nasser Altorki
1 reference
27 April 2016
1 reference
1 reference
17
1 reference
6
1 reference
822-835
1 reference
Identifiers
1 reference
1 reference